H008

Jiangsu Carephar Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	H008
Sponsor	Jiangsu Carephar Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

H008 CI brief — competitive landscape report
H008 updates RSS · CI watch RSS
Jiangsu Carephar Pharmaceutical Co., Ltd. portfolio CI